A recent clinical trial found that PARP inhibitors can be used to treat advanced male prostate cancer with BRCA1/BRCA2 gene mutations. The relevant results of the study have been published in […]
With upgrading of technologies and better understanding of diseases, the death rate caused by cancers is considerably decreased. According to the 2017 Cancer Progress Report released by the American Association […]